Coastar Therapeutics Inc.
October 18, 2023
Franciscan B
Gene/Cell Therapy
Coastar Therapeutics is a San Diego based company focusing on systemic gene delivery technology. The company has developed a novel ENHEnS technology that can coat human cell membrane on each individual virus to evade immune system recognition and clearance. This technology is also applicable to non-viral gene delivery, for example DNA and RNA.
Company Type
Privately Funded
Website
http://coastartherapeutics.com
CEO/Top Company Official
Eddie Chung
Lead Product in Development
The lead product is for gene therapy for solid tumors. Coastar has seen the significant improvement on efficacy after applying the ENHEnS technology. This product is expected to start the clinical development at late 2024.
Number Of Unlicensed Products
1